 Profile
| As a professional scientist at the Schering–Plough Research Institute in Kenilworth, New Jersey, Sam Wainhaus primarily assists the pharmaceutical industry in developing new drugs that take into account toxicity, efficacy, and human pharmacokinetics. Dr. Wainhaus currently serves as Group Leader II in the Department of Exploratory Drug Metabolism at Schering–Plough Research Institute. In his capacity, Dr. Wainhaus leads a team of six fellow scientists as they leverage their collective academic and scientific backgrounds to help humanity through research, testing, and drug development. Dr. Wainhaus’ research activities have been published in numerous journals, papers, and formal abstracts. Working on high throughput hyphenated MS techniques for pharmaceuticals, Dr. Wainhaus has also explored the areas of ultra fast liquid chromatography, novel orally active ureido NPY Y5 receptor antagonists, MS/MS for pharmacokinetic, and metabolic profiling, as well as the determination of activation energies for ion fragmentation by surface-induced dissociation and mass spectrometry usage for drug metabolism studies. Dr. Wainhaus graduated from Brooklyn College in New York in 1990, taking his Bachelor of Science degree in Chemistry. Dr. Wainhaus went on to the University of Illinois at Chicago, where he obtained his Ph.D. in the same field after six years of intensive study.
|
|
